Edition:
United Kingdom

TG Therapeutics Inc (TGTX.OQ)

TGTX.OQ on NASDAQ Stock Exchange Capital Market

4.76USD
15 Feb 2019
Change (% chg)

$0.06 (+1.28%)
Prev Close
$4.70
Open
$4.71
Day's High
$4.81
Day's Low
$4.67
Volume
309,036
Avg. Vol
406,645
52-wk High
$17.30
52-wk Low
$3.41

Chart for

About

TG Therapeutics, Inc. (TG) is a biopharmaceutical company focused on the acquisition, development and commercialization of treatments for B-cell malignancies and autoimmune diseases. As of December 31, 2016, the Company was developing two therapies targeting hematological malignancies. TG-1101 (ublituximab) is a glycoengineered... (more)

Overall

Beta: 1.34
Market Cap(Mil.): $846.68
Shares Outstanding(Mil.): 68.84
Dividend: --
Yield (%): --

Financials

  TGTX.OQ Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -1.95 -- --
ROI: -129.83 8.92 14.45
ROE: -133.51 10.08 15.96

Earnings vs. Estimates